Moreover, shRNA-mediated depletion of MDC1 resulted in olaparib resistance in the human high-grade serous ovarian cancer cell line PEO1, that carries the BRCA2 c.5193C>G mutation leading to a complete loss of protein stability (Fig. 1F, G). Here, MDC1 is linked to ovarian serous adenocarcinoma.